Prescription RequiredCrizotinib 250 mg (Crizokast) is a targeted anticancer medicine used to treat ALK-positive or ROS1-positive non-small cell lung cancer (NSCLC). It works by blocking abnormal proteins that promote cancer cell growth and spread, helping slow disease progression and improve treatment outcomes.
| Generic name | Crizotinib |
| Strength | 250 mg |
| Manufacturer | Aprazer |
| Package size | 60 Capsules |
| Used for | ALK-positive or ROS1-positive non-small cell lung cancer (NSCLC) |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Crizotinib is a tyrosine kinase inhibitor (TKI). It works by blocking abnormal ALK and ROS1 proteins that send signals for cancer cell growth and survival. This helps stop cancer cells from multiplying and slows the spread of the disease.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.
